AU3819002A - Monitoring the occurence of apneic and hypopneic arousals - Google Patents

Monitoring the occurence of apneic and hypopneic arousals Download PDF

Info

Publication number
AU3819002A
AU3819002A AU38190/02A AU3819002A AU3819002A AU 3819002 A AU3819002 A AU 3819002A AU 38190/02 A AU38190/02 A AU 38190/02A AU 3819002 A AU3819002 A AU 3819002A AU 3819002 A AU3819002 A AU 3819002A
Authority
AU
Australia
Prior art keywords
skin conductance
patient
apneic
hypopneic
heart rate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38190/02A
Inventor
John William Ernest Brydon
Gregory Alan Colla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Resmed Pty Ltd
Original Assignee
Resmed Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU16350/00A external-priority patent/AU743765B2/en
Application filed by Resmed Pty Ltd filed Critical Resmed Pty Ltd
Priority to AU38190/02A priority Critical patent/AU3819002A/en
Publication of AU3819002A publication Critical patent/AU3819002A/en
Abandoned legal-status Critical Current

Links

Landscapes

  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Description

S&F Ref: 288512AUD2
AUSTRALIA
PATENTS ACT 1990 COMPLETE SPECIFICATION FOR A STANDARD PATENT
ORIGINAL
Name and Address of Applicant: Actual Inventor(s): Address for Service: Invention Title: ResMed Limited 97 Waterloo Road North Ryde New South Wales 2113 Australia Gregory Alan Colla John William Ernest Brydon Spruson Ferguson St Martins Tower,Level 31 Market Street Sydney NSW 2000 (CCN 3710000177) Monitoring the Occurence of Apneic and Hypopneic Arousals The following statement is a full description of this invention, including the best method of performing it known to me/us:- 5845c -1- Monitoring the Occurrence of Apneic and Hypopneic Arousals Field of the Invention This invention relates to methods and apparatus for the determination or monitoring of arousals that are indicative of an apneic or hypopneic episode. An "A/H episode", as used hereafter, is to be understood as including both obstructive apneas (lack of breathing) or hypopneas (reduction in breathing) occurring during sleep.
Background of the Invention People suffering from Obstructive Sleep Apnea (OSA) and related conditions experience many A/H episodes during sleep. The conventional treatment for OSA is the well known Continuous Positive Airway Pressure (CPAP) treatment. An A/H episode often has an associated arousal, which is a nervous system response to low blood oxygen level and/or high blood carbon dioxide level.
The condition of OSA normally is diagnosed by laboratory based polysomnography (PSG). PSG involves the measurement of sleep and respiratory variables including EEG, EOG, chin EMG, ECG, respiratory activity, nasal airflow, chest and abdominal movements, abdominal effort and oxygen saturation. The data gathered leads to a calculation of the Respiratory Disturbance Index (RDI) which is the average number of arousals per hour due to respiratory disturbance. PSG is uncomfortable for a patient due to the placement of numerous electrodes on the patient's head or face and the wearing of a mask or nasal prongs. PSG is an expensive procedure and has the inconvenience of requiring the patient to attend a sleep clinic for a whole night requiring continuous technician attendance.
In-the clinic, cortical arousals can be detected by measuring and interpreting, either automatically or by eye, changes in the patient's EEG and EMG. Arousals are an important indicator of the amount and quality of sleep obtained by a patient and the degree of severity of the patient's apneas.
-2- To obtain a display of the EEG, electrodes must be attached to the patient's head and the signals from these electrodes passed through high gain amplifiers before subsequent display and recording. This is often inconvenient and time consuming; the signals also can become distorted or disappear due to electrode dislodgement or other artefacts such as sweating. To detect an arousal, the EEG, once displayed, requires interpretation either visually by a skilled operator or automatically by a computer-based analysis system. Apart from the difficulties of attaining accurate EEG data, EEG apparatus also is relatively more expensive than much other biomedical apparatus.
EEG data on its own is not an accurate determination of the occurrence of A/H episodes an arousal can be due to other factors as noted.
Prior art disclosures that form background information to the present invention include R. Ferber, et al, "ASDA Standards of Practice Portable Recording in the Assessment of Obstructive Sleep Apnea", Sleep, 17(4): 378-392, 1994; L. Ferini- Strambi, et al, "Heart rate variability during sleep in snorers with and without obstructive sleep apnea, Chest, 102(4): 1023-7, Oct. 1992; and C. Guilleminault, et al, "A review of 50 children with obstructive sleep apnea syndrome", Lung, 159:275-287, 1981.
Summary of the Invention It is an object of the present invention to overcome or at least ameliorate one or more of the problems with the prior art.
It has been determined that the coincident occurrence of change in the sympathetic physiological variable of sweating and another physiological variable is indicative of an arousal associated with an apneic or hypopneic episode. The occurrence of arousals associated with apneic or hypopneic episodes can be monitored by way of sensor means for obtaining two or more signals each indicative of sympathetic nervous system activity from a patient, one said signal representative of skin conductance and or each other signal representative of other sympathetic nervous system variables.
Correlation can be performed on the skin conductance signal and at least one other signal.
A coincident change in the correlated signals is indicative of the occurrence of an arousal.
[R:\LIBQ]01216.doc:edg The correlation can be other than a correlation in the strict mathematical sense, including coincident visual inspection, logical ANDing, indicator voting or weighted sums relative to a threshold.
Preferably, the sensor means comprises electrodes attachable to a patient's body.
The signals derived from the electrodes can be signal-conditioned. Furthermore, the correlation can be preformed by data processor means. Each said signal can have an associated confidence level so that a weighting can be applied in the correlation.
Changes in physiological states can include reduction in blood oxygen saturation, change in heart rate, change in skin conductance, change in skin temperature, and increase in blood pressure.
Embodiments of the invention have the advantage of being non-invasive. This is of particular importance when diagnosis of conditions such as OSA must be undertaken on a baby or small child who may be disturbed by the conventional PSG apparatus.
One embodiment, relating to apparatus for the acquisition of data from which the diagnosis of apneic or hypopneic episodes, and thus the likelihood of the presence of conditions including OSA exist in a patient, can, in the first instance, substitute for a conventional sleep study and allow a candidate to collect data when in the home in a noninvasive manner. The data then can be analysed by a medical practitioner and a determination made of whether further detailed investigations need to be conducted.
Accordingly, an aspect of the invention provides apparatus for acquisition of data from which the diagnosis of apneic or hypopneic episodes can be made, comprising: sensor means for obtaining two or more signals each indicative of sympathetic nervous system activity from a patient, one said signal representative of skin conductance and the or each other signal representative of other sympathetic nervous system variables; and a memory for storing a time sequence of said signals for subsequent analysis.
According to another aspect of the present invention, there is provided apparatus for determining the occurrence of apneic and hypopneic arousals in a patient comprising: a skin conductance sensor connected to an extremity of the patents; [RLIBQ]01216.doc:edg apparatus for processing the skin conductance sensor output to determine whether the skin conductance sensor output indicates an apneic or hypopneic arousal; a heart rate sensor connected to an extremity of the patient; apparatus for processing the heart rate sensor output to determine whether the heart rate sensor output indicates an apneic or hypopneic arousal; and apparatus for determining whether a positive indicator in skin conductance coincides with a positive indicator in heart rate.
According to a further aspect of the present invention, there is provided a method of determining the occurrence of apneic and hypopneic arousals in a patient in an overnight study comprising the steps of: monitoring the variation in a patient's skin conductance and at least one other physiological variable indicative of sympathetic nervous system activity; providing no CPAP treatment during a first portion of the overnight study; is providing CPAP treatment during a second portion of the overnight study; and determining that an apneic or hypopneic arousal has occurred when a positive indicator in skin conductance coincides with a positive indicator in at least one other said physiological variable.
Brief Description of the Drawings Fig. 1 is a schematic block diagram of diagnostic apparatus embodying the invention; THE NEXT PAGE IS PAGE 6 (R:\LIBQ]01216.doc:edg Fig. 2 is a schematic block diagram of a circuit for measuring skin conductance; Fig. 3 is a plot of skin conductance with time; Fig. 4 is a plot of skin conductance together with airflow rate, heart rate and SaO 2 and Fig. 5 is a plot of skin conductance measured periodically both before and during CPAP treatment is implemented.
Description of Preferred Embodiments The sequence of events leading to an arousal due to an apnea or hypopnea are as follows: 1. The patient's upper airway obstructs as they try to inspire, or the central nervous system drive to breathe is inhibited and the patient makes no effort to breathe.
2. The oxygen level in the patient's arterial blood begins to fall and the carbon dioxide level rises.
3. After some time, which may exceed a minute, blood gas sensitive receptors in the carotid and/or aortic arteries force an arousal causing the patient to partially wake and recommence breathing.
This sequence is associated with a number of physiological changes (apart from those of the EEG referred to above) some of which are driven by the sympathetic nervous system which can be monitored: 1. A fall in blood oxygen saturation (SaO 2 with subsequent post-apneic rise. SaO 2 can be measured by pulse oximetry.
2. A decrease in heart rate as the patient's hypercapnia increases, followed by an increase when they arouse and restart breathing. Heart rate can be measured by ECG techniques.
3. A change in skin conductance due to sweating, measured by application of an electrical potential to measure conductance/impedance.
4. Increase in blood pressure. Blood pressure can be measured by continuous sphygomomanometry.
5. Change in constriction of blood vessels in the skin leading to a change in skin temperature and a change in tissue volume, particularly that in the fingers. This can be measured by plethysmography.
6. A reduction in breathing sounds as the apnea occurs followed by a snore or snort when the apnea is broken.
Taken separately, each of the above changes is only ambiguously related to an arousal after an obstructive event. Each also is subject to artefacts in the signal which are a function of how it is measured. However, by combining several of the above measurements, a much more artefact-free and specific diagnostic indicator of an arousal due to an A/H episode can be obtained.
Fig. 1 shows a plurality of sensors 1 0 1-10n from which signals of the type described above are obtained from the patient. The sensors typically will comprise a sensing portion to detect physiological functions such as blood oxygen saturation, heart rate, skin conductance, blood pressure, skin temperature and audible noises, coupled with amplifying/buffering devices to derive an electrical signal.
The electrical signals each are passed to a corresponding preprocessing section 121-12 n The conditioning typically can include averaging, thresholding linearisation and differentiation for those signals which exhibit a marked change. Each of the n signals has a characteristic pattern or range of patterns associated with apneic and hypopneic events. Each matching pattern serves as an indicator for an apneic or hypopneic event. A characteristic pattern for each signal is as follows.
1. The blood oxygen saturation signal (SaO 2 is low-pass filtered, resulting in a baseline value. Signal values which differ from the baseline by a predetermined threshold, typically are positive indicators.
2. The heart rate signal is low-pass filtered to remove high frequency components, including the sinus rhythm. This signal is then differentiated, so that changes in the heart rate are evident. A fall in the heart rate followed by a marked increase in heart rate is an indicator. When the difference between the slowest and fastest heart-rate is greater than a specified minimum, typically beats per minute, the indicator scores positively.
3. The skin conductance is low-pass filtered, resulting in a baseline value, then is high-pass filtered to accentuate changes. When the conductance increases above a specific ratio of the baseline, typically 100%, the indicator scores positively.
4. The blood pressure signal (both systolic and diastolic) is low-pass filtered to produce a baseline value. The elevation of the blood pressure by more than a predetermined threshold, typically 25%, results in a positive indicator.
5. The skin temperature is low-pass filtered to produce a baseline value.
If the skin temperature falls below a specific threshold from the baseline, typically between 0.5 and 1.0°C, the indicator is positive.
6. Breathing sounds are band-pass filtered, typically between 30 and 300 Hz. The energy from this signal is estimated by squaring or rectifying the filtered signal, and is used as a measure of snore intensity. A significant fall in the snore intensity, typically by 6 dB, followed by a sharp increase, is a positive indicator.
The conditioned signals 141-14n, together with a quality signal 161-16 n giving a measure of the quality (confidence) of the signal, are passed to a multi-input processing device 18. The multiple input signals are processed algorithmically, with ones of the signals 14 having the higher quality factor being given more weight.
The detection of an isolated matching pattern does not signify an apneic or hypopneic event. However, the coincidence of two or more of these indicators increases the confidence of event detection. Various algorithms can be used: 1. Indicator ANDing, whereby each of the indicators must be positive to indicate an arousal.
2. Indicator voting, whereby most of the indicators must be positive to indicate an arousal.
3. Weighted sum, whereby each of the indicators has a predetermined weight. The products of each indicator and its weight are accumulated. The sum indicates an arousal if the sum is above a predetermined threshold.
The processing device 18 thus makes a determination of whether an arousal associated with an A/H episode has occurred, and further determines the percentage chance that this 'diagnosis' is correct, and yet further provides a determination of the duration of the A/H episode that preceded the arousal. These determined functions are logged to a memory device 20 for subsequent analysis, for example by plotting with time and observing coincidences, and also can be indicated on a display device 22 in real time.
From this information an index of arousals can be compiled, typically as arousals per hour, providing an alternative indicator to ROI, as previously discussed, to serve as a useful indicator of sleep quality.
In another embodiment the signals obtained from the sensors can be directly stored in the memory device 20 in a time sequence for subsequent correlative processing by the processing device 18, or by a processor independent of the data acquisition module. This embodiment can serve as a data acquisition device for home usage, with the correlative processing occurring at a medical practitioner's surgery (for example) at a later time.
Particular embodiments now will be described, relating to clinical measurements performed on three patients, and for which the physiological variables measured include skin conductance and heart rate (particularly cardiac rate, both of which are sympathetic variables).
Heart rate is measured by a conventional technique, namely three lead EGG.
It is preferred that the electrodes are located at the patient's body's extremities to avoid apprehension and reduce the likelihood of unwanted artifacts due to gross body movement.
The skin conductance measurement similarly is performed at the body's extremities, in one case being on the sole of a foot where sweat glands are concentrated. An alternate site is the forehead. Skin conductance is to be understood as the reciprocal of skin resistance, which is affected by sweating. In the complex number domain, conductance is the real part of skin admittance. As follows, skin also exhibits a reactive property (essentially a capacitance), the reciprocal of which is the susceptance.
Fig. 2 shows a schematic block diagram of a skin conductance measurement system 30 representing one form of a sensor 10 and preprocessing section 12. An oscillator 32 applies a 1 kHz signal of approximately 0.6 Vpp signal between two electrodes placed apart on the sole of the patient's foot, thereby applying an excitation to the patient's skin 34. The current passing through the electrodes is dependent upon the conductance and susceptance of the skin and interconnecting tissue.
A sense resistor 36 converts the current to a signal voltage cS, which is amplified by an amplifier 38. A demodulator circuit 40,42 removes the effects of the skin susceptance due to the skin's capacitance) from the amplified signal C s so that the resulting signal, SCL, is proportional to the skin conductance (level). The baseline of the SCL is removed by a high pass filter 44 and amplified (not shown) so that responses to arousals are accentuated and more easily monitored. The resultant signal, SCR, is indicative of the skin conductance response.
Fig. 3 shows a time window of one half an hour during a sleep study performed on a patient known to be a sufferer of Obstructive Sleep Apnea. The upper -11 trace represents the skin conductance SCL, and the lower trace the skin conductance response SCR. The sensed response at approximately t 267.5 minutes corresponded with an apneic arousal otherwise determined by PSG. Skin conductance thus is a reliable partial indicator of an arousal associated with an A/H episode.
Fig. 4 shows an excerpt from a sleep study conducted on a different patient showing a relevant 30 minute window. The patient is a known sufferer of OSA. The uppermost trace is heart rate filtered over one minute to remove sinus rhythm. The units are beats per minute, and the measurement is made with a pulse oximeter. The second trace (in descending order) is blood oxygen saturation (SaO 2 also measured with a pulse oximeter. The scale is 0-100%. The third trace is the SCR phase reference signal and the fourth trace the SCL base reference signal as measures of skin conductance. The units of conductance are relative only. The lowermost trace is of respiratory airflow measured with nasal cannulae and a pressure transducer.
Fig. 4 shows a continuous decrease in nasal airflow until approximately t 11 minutes corresponding to a hypopneic event. At this point nasal airflow increased with the taking of a sudden deep breath. The SaO 2 trace shows a corresponding fall of approximately which, because of heavy filtering, appears after the resumption of normal breathing, although in fact was coincident with the sudden deep breath. The chain of events was shallow breathing (hyponea), followed by a fall in SaO 2 followed by a resumption of normal breathing. Associated with the arousal causing the resumption of normal breathing is tachycardia, with the heart rate increasing by about bpm. The arousal is coincident in time with the sudden increase in skin conductance and heart rate. Thus these two quantities can be utilised in concert as an indicator of arousals associated with A/H episodes.
Interestingly, at approximately t 20 minutes, there is a sudden interruption in respiratory airflow as a result of the patient sighing, however there is no corresponding indicator in either skin conductance or heart rate to suggest that the cessation of flow was due to an apnea.
12- The data indicates that the correlation of skin conductance with one or more other physiological variables (whether associated with the sympathetic nervous system or not) or any two or more sympathetic physiological variables (for example blood pressure and heart rate), is an accurate determinant of the occurrence of an arousal associated with an A/H episode. Further, it is believed that the correlation of two sympathetic physiological variables, not necessarily including skin conductance, and for example heart rate and blood pressure, also is an accurate determinant.
Fig. 5 shows a plot of the variance of skin conductance for the third patient during a sleep study in which between t 20:30 hours and t 1:15 hours no CPAP treatment was in place, and between t 1:15 hours and t 5:30 hours CPAP treatment was in place. The sampling points are at five minute epochs. The 10 and centiles have been shown. The plot indicates the reduction in variance of skin conductance both before and after the commencement of CPAP treatment as an indication of the reduction in the number of arousals due to A/H episodes and thus the reliability of skin conductance as a partial indicator of A/H episodes.
In summary, embodiments of the invention can serve to monitor the occurrence of apneic or hypopneic episodes, to diagnose the occurrence of A/H episodes resulting in arousals, to acquire data from which the diagnosis of A/H episodes resulting from arousals can be made, to determine an index of sleep quality, and to monitor the sympathetic nervous system.

Claims (7)

1. Apparatus for acquisition of data from which the diagnosis of apneic or hypopneic episodes can be made, comprising: sensor means for obtaining two or more signals each indicative of sympathetic nervous system activity from a patient, one said signal representative of skin conductance and the or each other signal representative of other sympathetic nervous system variables; and a memory for storing a time sequence of said signals for subsequent analysis.
2. Apparatus for determining the occurrence of apneic and hypopneic arousals in a patient comprising: a skin conductance sensor connected to an extremity of the patents; apparatus for processing the skin conductance sensor output to determine whether the skin conductance sensor output indicates an apneic or hypopneic arousal; a heart rate sensor connected to an extremity of the patient; apparatus for processing the heart rate sensor output to determine whether the heart rate sensor output indicates an apneic or hypopneic arousal; and apparatus for determining whether a positive indicator in skin conductance coincides with a positive indicator in heart rate.
3. Apparatus as claimed in claim 2 wherein the extremity to which the skin conductance sensor is connected is the sole of the patient's foot.
4. Apparatus as claimed in clam 2 wherein the extremity to which the skin conductance sensor is connected is the patient's forehead. Apparatus as claimed in claim 2 wherein the heart rate is measured using three lead ECG.
6. Apparatus as claimed in claim 2 wherein the heart rate is measured using a pulse oximeter.
7. A method of determining the occurrence of apneic and hypopneic arousals in a patient in an overnight study comprising the steps of: [R:\LIBQ]O 1216.doc: edg
14- monitoring the variation in a patient's skin conductance and at least one other physiological variable indicative of sympathetic nervous system activity; providing no CPAP treatment during a first portion of the overnight study; providing CPAP treatment during a second portion of the overnight study; and s determining that an apneic or hypopneic arousal has occurred when a positive indicator in skin conductance coincides with a positive indicator in at least one other said physiological variable. 8. A method as claimed in claim 7 whereby the first portion of the overnight study occurs from approximately 20:30 hours to 1:15 hours. 9. A method as claimed in claim 7 whereby the second portion of the overnight study occurs from approximately 1:15 hours to 5:30 hours. 10. A method as claimed in claim 7 further including the step of determining an index of sleep quality from the number of apneic and hypopneic arousals which have been determined during the study. DATED this Third Day of May, 2002 ResMed Limited Patent Attorneys for the Applicant SPRUSON FERGUSON [R:\LIBQ]O 216.doc:edg
AU38190/02A 1995-04-11 2002-05-03 Monitoring the occurence of apneic and hypopneic arousals Abandoned AU3819002A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU38190/02A AU3819002A (en) 1995-04-11 2002-05-03 Monitoring the occurence of apneic and hypopneic arousals

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPN2365 1995-04-11
AU16350/00A AU743765B2 (en) 1995-04-11 2000-02-11 Monitoring the occurence of apneic and hypopneic arousals
AU38190/02A AU3819002A (en) 1995-04-11 2002-05-03 Monitoring the occurence of apneic and hypopneic arousals

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU16350/00A Division AU743765B2 (en) 1995-04-11 2000-02-11 Monitoring the occurence of apneic and hypopneic arousals

Publications (1)

Publication Number Publication Date
AU3819002A true AU3819002A (en) 2002-06-20

Family

ID=25616311

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38190/02A Abandoned AU3819002A (en) 1995-04-11 2002-05-03 Monitoring the occurence of apneic and hypopneic arousals

Country Status (1)

Country Link
AU (1) AU3819002A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111467644A (en) * 2013-07-08 2020-07-31 瑞思迈传感器技术有限公司 Method and system for sleep management

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111467644A (en) * 2013-07-08 2020-07-31 瑞思迈传感器技术有限公司 Method and system for sleep management

Similar Documents

Publication Publication Date Title
US6363270B1 (en) Monitoring the occurrence of apneic and hypopneic arousals
AU2018253518B9 (en) Methods for detection of respiratory effort and sleep apnea monitoring devices
US6936011B2 (en) Analysis of sleep apnea
AU2005204433B2 (en) Method and apparatus for ECG-derived sleep disordered breathing monitoring, detection and classification
CA2602870C (en) Method and apparatus for diagnosing respiratory disorders and determining the degree of exacerbations
US20100030085A1 (en) System for monitoring and analysing cardiorespiratory signals and snoring
US20060241510A1 (en) Techniques for prediction and monitoring of clinical episodes
AU2001237695B2 (en) Method and apparatus for the non-invasive detection of particular sleep-state conditions by monitoring the peripheral vascular system
WO2006082589A2 (en) Detection and monitoring of stress events during sleep
AU2001237695A1 (en) Method and apparatus for the non-invasive detection of particular sleep-state conditions by monitoring the peripheral vascular system
KR100662103B1 (en) Method and apparatus for diagnosing sleep apnea and treating according to sleep apnea type
JP2000325315A (en) Sleep stage determinig method and sleep stage determining device
AU743765B2 (en) Monitoring the occurence of apneic and hypopneic arousals
AU3819002A (en) Monitoring the occurence of apneic and hypopneic arousals
Chokroverty et al. Patient Preparation and Laboratory Environment
Chokroverty et al. Polysomnographic Recording